Evidence map›Paper›PMID 14675633›Full record

ArticleVirology2003

Analysis of synergy between divergent simple retrovirus posttranscriptional control elements.

Stacey Hull, Kathleen Boris-Lawrie

Open access · greenAbstract read
In one paragraph

Article in Virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Translational control of retroviruses.Nature reviews. Microbiology · 2007
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stacey HullCenter for Retrovirus Research, The Ohio State University, Columbus, OH 43210-1093, USA.
Kathleen Boris-Lawrie
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
HIV STRUCTURAL GENE VECTORS--LIVE-ATTENUATED HIV VACCINER21AI046325 · NIAID · OHIO STATE UNIVERSITY · PI BORIS-LAWRIE, KATHLEEN A · 1999 to 2000
$219k
NCI NIH HHS P30 CA016058NCI NIH HHS P30CA16058NIAID NIH HHS R21 AI046325PHS HHS R29A146325
6 · The paper itself

Abstract

Mason-Pfizer monkey virus (MPMV) and spleen necrosis virus (SNV) are simple retroviruses that encode functionally divergent cis-acting RNA elements that use cellular proteins to facilitate nuclear export and translation of unspliced viral RNA. We tested the hypothesis that a combination of MPMV constitutive transport element (CTE) and SNV or MPMV RU5 translational enhancer on unspliced HIV-1 gag-pol reporter RNA synergistically augments Gag production. Results of transient transfection assays validate the hypothesis of synergistic augmentation in COS cells, but not 293 cells. RNA targeting experiments verified comparable responsiveness to CTE-interactive proteins tethered by RRE and RevM10Tap in COS and 293 cells. Exogeneous expression of Tap and NXT1 was necessary and sufficient to rescue Gag augmentation in 293 cells. Overexpression experiments established that CTE, but not RU5, confers the responsiveness to Tap and NXT1 and that CTE in conjunction with Tap and NXT1 conferred a 30-fold increase in translational utilization of the cytoplasmic RNA. Our results uncovered a previously unidentified role of CTE in conjunction with Tap and NXT1 in commitment to efficient cytoplasmic RNA utilization.

Indexed as

Protein Biosynthesis5' Untranslated RegionsAnimalsCell LineCOS CellsCytoplasmEnhancer Elements, GeneticFusion Proteins, gag-polGammaretrovirusGene Expression RegulationGene Products, gagGenes, ReporterHIV-1HumansMason-Pfizer monkey virusRNA, Messenger5' Untranslated RegionsFusion Proteins, gag-polGene Products, gagRNA, MessengerRNA, Viral

Identifiers

PMID14675633
PMCPMC4862584
OpenAlexW2022895081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.